ArticleCardiovascular drugs and therapy2026
Beyond KPAQ Improvement: Reassessing the Clinical Meaning of Cilostazol-Rosuvastatin Combination Therapy in Symptomatic Peripheral Artery Disease.
Junao ChenPubMed ↗Publisher ↗
No numbers read from the abstract.